Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals
Journal of Medicinal Chemistry · 11.09.2025 · 68 (17) · 18356-18369
DOI: 10.1021/acs.jmedchem.5c01014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 02.09.2025. Verfasst von Manisha Saini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States. Hauptthemen laut MEDLINE: Dengue Virus, Antiviral Agents, Viral Nonstructural Proteins, RNA-Dependent RNA Polymerase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Dengue viruses (DENVs) infect approximately 400 million people each year, and currently, there are no effective therapeutics available. To explore potential starting points for antiviral drug development, we conducted a large-scale crystallographic fragment screen targeting the RNA-dependent RNA polymerase (RdRp) domain of the nonstructural protein 5 (NS5) from DENV serotype 2. Our screening, which involved 1108 fragments, identified 60 hit compounds across various known binding sites, including the active site, N pocket, and RNA tunnel. Additionally, we discovered a novel binding site and a fragment-binding hot spot in thumb site II. These structural findings open amenable avenues for developing non-nucleoside inhibitors and offer valuable insights for future structure-based drug design aimed at DENV and other flaviviral RdRps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.
- Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.
- Diamond Light Source, Harwell Science and Innovation Campus, Fermi Avenue, Didcot OX11 0DE, U.K.
- Research Complex at Harwell, Harwell Science and Innovation Campus, Fermi Avenue, Didcot OX11 0FA, U.K.
- Centre for Medicines Discovery, Nuffield Department of Medicine Research Building, Old Road Campus, Headington, Oxford OX3 7FZ, U.K.
ORCID-Profile: Francesc Xavier Ruiz, Daren Fearon, Eddy Arnold
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Saini, M., Aschenbrenner, J. C., Ruiz, F. X., Chopra, A., Chandran, A. V., Marples, P. G., Balcomb, B. H., Fearon, D., von Delft, F., & Arnold, E. (2025). Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals. Journal of Medicinal Chemistry, 68(17), 18356-18369. https://doi.org/10.1021/acs.jmedchem.5c01014
Vancouver
Saini M, Aschenbrenner JC, Ruiz FX, Chopra A, Chandran AV, Marples PG, et al. Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals. Journal of Medicinal Chemistry. 2025;68(17):18356-18369. doi:10.1021/acs.jmedchem.5c01014
BibTeX
@article{Saini2025,
author = {Saini, Manisha and Aschenbrenner, Jasmin C and Ruiz, Francesc Xavier and Chopra, Ashima and Chandran, Anu V and Marples, Peter G and Balcomb, Blake H and Fearon, Daren and von Delft, Frank and Arnold, Eddy},
title = {Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside Antiflavivirals},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {17},
pages = {18356--18369},
doi = {10.1021/acs.jmedchem.5c01014}
}
EUVIMED